REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $145,803 | +30.4% | 1,430,004 | +16.3% | 6.76% | +23.1% |
| Q1 2023 | $111,832 | -99.8% | 1,230,004 | 0.0% | 5.49% | +123.1% |
| Q4 2022 | $46,727,852 | +50.1% | 1,230,004 | -0.7% | 2.46% | +40.7% |
| Q3 2022 | $31,136,000 | -17.3% | 1,239,000 | 0.0% | 1.75% | -26.6% |
| Q2 2022 | $37,653,000 | -7.2% | 1,239,000 | 0.0% | 2.38% | +14.3% |
| Q1 2022 | $40,590,000 | +1347.1% | 1,239,000 | +2378.0% | 2.09% | +501.2% |
| Q4 2018 | $2,805,000 | -91.4% | 50,000 | -87.5% | 0.35% | -90.4% |
| Q3 2018 | $32,704,000 | +187.8% | 400,000 | +23.1% | 3.63% | +182.0% |
| Q2 2018 | $11,365,000 | +70.5% | 325,000 | 0.0% | 1.29% | +80.8% |
| Q1 2018 | $6,666,000 | +7.2% | 325,000 | +62.5% | 0.71% | -49.7% |
| Q3 2017 | $6,220,000 | – | 200,000 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |